Sep 2026 · Disclosure Of Events/ Information Under Regulation 30 Of SEBI LODR Regulations, 2015 12 Aug - DOMS Industries AGM scheduled for September 3, 2026; annual report FY2025-26 shared via web-link.
Source: Bse
FMCG stocks · Large cap · NSE
DOMS Industries Limited manufactures and markets a wide range of stationery and art materials. The company focuses on new product launches, expanding distribution, and increasing manufacturing capacity. It also operates in the baby hygiene segment through its Uniclan business.
full bear SMA stack · SMA20 -4.4% / mo · MACD + · near 52W low · sector -4.5pp vs Nifty 500 (3M)
Latest mapped FPI equity flow was not positive. View sector evidence
Adjusted completed-session prices, rebased to 100
Mixed fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend argues for patience, and recent execution is consistent.
Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.
Revenue +19.4% · PAT -23.7% YoY
Price trend and sector-relative-strength timing.
Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.
Financial-only signal; management claim evidence is not sufficient yet.
Fundamentals, quarterly history, margins, returns and balance-sheet evidence
PAT -24% YoY · margin compression · Rev +19% YoY · +11% QoQ
| Metric | This quarter | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹671 Cr | +19.4% | +11.1% |
| EBITDA | ₹83 Cr | -16.2% | -17.8% |
| Operating margin | 12.0% | -600 bps | -500 bps |
| PAT | ₹45 Cr | -23.7% | -22.4% |
| PAT margin | 6.7% | -379 bps | -289 bps |
NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.
Updated 20/10/2026
Trend interpretation, Stage 2, relative strength, volume and indicator evidence
Signals are conflicting — long-term trend down. RSI 43. Wait for confirmation.
Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.
U-Score 54 · legacy U-Score band FAIR VALUE · valuation evidence and comparable companies
Top U-Score contributors and drags from the latest stored fundamentals.
Consumer franchises can deserve higher multiples, but only when growth quality supports them.
This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.
12 stored score snapshots. Latest stored move: +0 points.
Business-comparable peers in FMCG — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.
Growth engines, risks, management commitments and evidence-backed delivery
FY26 revenue grew 21.6% to INR2,326.4 crores, surpassing guidance, driven by new products and buoyant demand. Q4 revenue rose 18.7% to INR604 crores. EBITDA margins softened in Q4 (16.7% vs 17.3% YoY) and FY26 (17.3% vs 18.2% YoY) due to Uniclan's higher contribution and e-commerce costs.
DOMS delivered strong revenue growth in FY26 and Q4, fueled by new product launches and robust domestic demand. However, significant raw material inflation (15-20% increase in crude-linked basket) and higher e-commerce related costs for the Uniclan segment are pressuring EBITDA margins. Management has implemented only 4-5% pricing actions, leading to near-term margin uncertainty for FY27.
New product launches across categories with attractive ergonomic and user-friendly designs resonated strongly with consumers and gained strong traction.
Witnessed sustained growth across all our product categories, with certain categories aided by capacity additions.
The demand scenario in the domestic market continues to remain buoyant and was a key contributor to growth, underpinned by strong entrenched distribution network.
Office supplies (ball point pens, highlighters) delivered very great growth. Company continues to invest significantly in writing instruments.
The company totally spent around INR292 crores in FY26 towards development of 45-acre land, acquisition of additional land, and procurement/installation of plant and machinery.
Company has lined up a capex plan between INR250 crores to INR275 crores for FY27.
The first building of our 45-acre facility is on track for completion in June 2027 with commercial production expected to commence towards the end of Q2 FY27.
Significant investments were done in expansion of moulding capacities, writing instruments, adhesive manufacturing infrastructure, and planned capex for wooden pencils.
The demand scenario in the domestic market continues to remain buoyant, underpinned by strong entrenched distribution network, robust brand equity and a well-diversified product portfolio.
Social media community scaled significantly: YouTube subscribers crossed 4 million, Instagram followers over 170,000, reinforcing DOMS as an admired brand.
New product launches across categories with attractive ergonomic and user-friendly designs resonated strongly with consumers and gained strong traction.
Elevated uncertainty and volatility primarily stemming from the ongoing developments in West Asia.
Significant increase in prices of raw material, with a significant portion of input basket directly linked to crude derivatives.
Moderation in EBITDA margin is partly due to the onset of the seasonal slowdown in the baby hygiene segment, which impacted fixed cost absorption.
A significant portion of our input basket is directly linked to crude derivatives, which makes cost trends especially sensitive and highly volatile to the developments in the West Asia conflict.
Aggressive pricing moves can sometimes lead to loss of shelf space to new entrants and existing competitors.
Increase in contribution of e-commerce sales in the baby hygiene segment led to higher advertising and marketing and freight expenses, impacting EBITDA margins.
Issuer guidance and extracted claims are tracked against later reported outcomes. Treat these as management statements, not IndiaPulse forecasts.
The company reports both full-year (FY26) and quarterly (Q4 FY26) results, comparing them to the corresponding previous periods (YoY). Quarterly sequential performance (QoQ) is also relevant for understanding the seasonal impact on the Uniclan business.
Revenue for the financial year 2026 grew by 21.6% to INR2,326.4 crores, surpassing our full year guidance.
Revenue for Q4 FY26 grew by 18.7% to INR604 crores, highlighting a sustained growth trajectory.
Consumption margins were broadly consistent for FY26 at 43.6% similar to FY25.
EBITDA margin softened to 17.3% as compared to 18.2% in FY25 on account of higher Uniclan contribution.
At consolidated level with the planned capacity expansion and the current demand trends, we expect revenue to grow by 17% to 20% in FY27.
Given the current commodity environment and volatility, we do expect margins in Q1 to remain slightly under pressure versus the corresponding period last year.
We do not view this as a structural revision of our margin – long-term margin profile, but more of temporary.
From a long-term perspective, we believe in this segment (Uniclan), we'll be happy to achieve a 10% sort of an EBITDA and stay at that level, maximizing revenue growth.
| Checkpoint | Current evidence | What to verify next |
|---|---|---|
| Raw Material Cost Trends | 15-20% inflation in crude-linked basket (peak). | Stabilization or correction in raw material prices, especially crude derivatives, to ease margin pressure. |
| Pricing Actions & Market Share | 4-5% pricing increase implemented so far. | Further calibrated pricing actions and their impact on market share and competitive positioning. |
| EBITDA Margin Recovery | Q4 FY26 EBITDA margin at 16.7%, FY26 at 17.3%. Expected Q1 FY27 pressure. | Signs of margin recovery in subsequent quarters, driven by cost efficiencies and effective pricing. |
| 45-Acre Facility Commercialization | First building completion June 2027, commercial production end of Q2 FY27. | Timely commissioning and ramp-up of production from the new facility to support growth. |
Verification checkpoints are IndiaPulse research interpretation, not investment advice.
Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.
Limited evidence: Claim history is still being built. It ranks around the 88th percentile of the scored universe and 70th percentile within FMCG. No major sub-score weakness stands out.
This is a financial-behaviour screen, not a claim-tested management reliability verdict.
Financial behaviour is scored, but management claims do not yet have enough outcome checks.
overall median 67 · FMCG: 70th pctile, median 79 · Large: 74th pctile, median 73
39 documents have extracted text, but claim history is not strong enough yet.
0 claims extracted · No contradicted claim yet
Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.
Read low sub-scores as due-diligence warnings, not automatic sell signals.
Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.
Latest exchange and company disclosures found within the past two years.
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse
Source: Bse